- Biogen's tau drug reports mixed Alzheimer's results, as low dose performs betterLONDON — Biogen's attempt to treat Alzheimer's by going after a protein that forms toxic tangles in the brain showed some of the strongest proof yet that it could slow dementia. But the results wer…Endpoints · 13d ago↗ source
- STAT+: Biogen Alzheimer’s drug slowed decline at rates on par with approved therapies, study showsAn experimental Alzheimer's drug from Biogen, one with a novel approach, slowed decline at comparable rates as approved drugs in a mid-stage study.STAT · 13d ago↗ source
- Draig nets $65M to advance depression drug aimed at rebuilding synapsesDraig Therapeutics has secured $65 million in an oversubscribed Series B raise to advance a pipeline of neuropsychiatry drugs, including its lead depression program designed to modulate the AMPA re…